Table 4.
Parameter | β-coefficient (95% CI) | P-value |
---|---|---|
Multivariable model for osteocalcina | ||
SLEDAI, units | −0.40 (−1.18, 0.37) | 0.31 |
Age, year | −2.59 (−3.95, −1.22) | <0.001* |
Weight, kg | −0.25 (−0.47, −0.02) | 0.03* |
Prednisone, mg/kg/day | −29.7 (−43.2, −16.3) | <0.001* |
25-OH vitamin D, ng/ml | −0.21 (−0.58, 0.17) | 0.19 |
1,25-OH2 vitamin D, ng/ml | 0.06 (−0.14, 0.26) | 0.54 |
TRAP, U/l | 3.16 (0.97, 5.4) | 0.005* |
Male gender | 15.5 (5.77, 25.1) | 0.002* |
Multivariable model TRAPb | ||
SLEDAI, units | −0.06 (−0.11, −0.002) | 0.04* |
Age, year | −0.12 (−0.22, −0.02) | 0.02* |
Height, cm | −0.02 (−0.05, 0.01) | 0.28 |
Weight, kg | 0.003 (−0.02, 0.02) | 0.78 |
25-OH vitamin D, ng/ml | 0.02 (−0.008, 0.05) | 0.16 |
Osteocalcin, ng/ml | 0.02 (0.0001, 0.03) | 0.049* |
NTxc | 0.002 (−0.001, 0.005) | 0.23 |
aMultivariable model examining predictors of osteocalcin shows that SLEDAI is not significantly associated with bone formation after controlling for confounders. Model-adjusted R2 = 0.37 (n = 130 observations, 77 subjects). bMultivariable model examining predictors of TRAP shows that SLEDAI is negatively associated with bone resorption after controlling for confounders. Model-adjusted R2 = 0.29 (n = 132 observations, 81 subjects). cBCE/mM creatinine. *P < 0.05.